Insys therapeutics, inc. (INSY)
Balance Sheet / Yearly
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
Assets
Current Assets:
Cash and cash equivalents

36,513

31,552

20,845

16,090

18,549

31,999

35,755

49,830

68,373

104,642

93,529

69,290

73,820

79,515

93,980

74,035

70,074

58,106

47,410

46,139

40,010

45,382

31,346

21,746

686

361

Short-term investments

47,380

64,126

79,719

88,813

-

85,189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

400

400

800

-

-

-

Short-term investments

-

-

-

-

95,895

-

85,891

91,786

86,914

78,238

76,122

89,081

89,808

79,576

61,490

41,248

31,386

24,757

15,415

8,599

6,910

-

-

-

-

-

Accounts receivable, net

6,087

12,610

12,717

20,067

15,761

21,513

23,249

23,972

13,313

20,654

33,561

39,399

20,663

47,272

30,437

34,572

31,617

26,544

27,659

15,687

19,053

16,313

12,376

9,130

5,817

3,089

Inventories, net

7,246

8,608

10,754

10,001

16,300

17,408

18,424

19,988

21,288

20,414

27,982

29,215

32,241

41,715

39,374

35,553

35,236

34,781

-

-

-

14,528

11,746

8,678

8,178

-

Inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,441

24,706

19,406

-

-

-

-

7,095

Prepaid expenses and other current assets

8,501

9,396

21,442

21,143

20,189

19,833

16,544

11,610

7,048

5,695

4,636

6,057

4,077

3,973

5,842

6,403

5,982

2,243

2,682

3,038

1,674

1,727

1,457

1,027

1,046

1,344

Total current assets

105,727

126,292

145,477

156,114

166,694

175,942

179,863

197,186

196,936

229,643

235,830

233,042

220,609

252,051

231,123

191,811

174,295

146,431

128,686

102,214

91,309

82,150

57,725

40,581

15,727

11,889

Property and equipment, net

47,810

52,086

53,180

52,892

54,777

55,174

53,931

49,139

46,009

43,172

41,267

39,930

39,618

38,382

36,748

35,479

33,846

29,872

24,104

17,434

12,620

10,127

8,267

8,156

6,467

6,791

Operating lease right-of-use assets

11,036

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

3,726

8,446

12,451

18,605

-

46,733

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

-

-

-

-

31,633

-

55,514

61,342

63,193

53,796

47,524

35,339

36,443

43,219

31,848

29,841

22,891

23,262

26,683

20,560

9,917

-

-

-

-

-

Deferred income tax assets, net

-

-

-

-

-

-

31,748

26,551

27,708

23,243

24,101

19,950

18,192

17,607

15,265

14,565

13,635

-

8,652

9,615

8,334

8,238

-

-

-

-

Deferred income tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,213

4,079

4,045

3,856

3,800

-

-

-

-

Other assets

4,301

5,703

6,383

7,534

835

1,231

2,030

3,410

3,750

6,282

7,505

10,170

11,165

26

26

3,518

3,518

3,343

26

43

43

43

44

37

37

61

Total assets

172,600

192,527

217,491

235,145

253,939

279,080

323,086

337,628

337,596

356,136

356,227

338,431

326,027

351,285

315,010

275,214

248,185

215,121

188,151

149,866

122,223

100,558

66,036

48,774

22,231

18,741

Liabilities and Stockholders' Deficit
Current Liabilities:
Accounts payable and accrued expenses (including accrued legal expenses of $56,843 and $32,625 at March 31, 2019 and December 31, 2018, respectively

67,095

50,778

46,047

33,569

29,440

30,438

31,226

23,016

28,205

27,359

18,774

22,200

24,590

35,611

22,445

30,626

28,434

27,454

24,534

15,070

16,714

12,173

12,221

7,841

7,452

6,479

Accrued compensation

2,640

6,437

5,941

5,322

4,014

8,808

5,376

5,443

4,236

8,833

7,697

9,104

7,239

10,225

10,189

8,719

7,009

6,926

7,354

6,140

4,487

3,568

3,030

2,288

2,163

1,392

Accrued sales allowances

7,157

8,162

9,301

12,582

12,833

16,290

20,855

20,085

19,352

28,955

41,859

31,717

29,742

35,033

31,855

20,352

21,326

11,296

11,300

7,124

3,724

5,340

-

-

-

-

Current portion of operating lease liabilities

1,839

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of uncertain income tax positions

1,219

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

1,109

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

144

144

508

-

Deferred patient discount program

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,557

1,494

1,591

1,540

Deferred revenue

-

-

-

-

-

-

940

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,510

2,820

3,614

3,767

Accrued litigation award and settlements

115,265

41,402

150,065

150,134

151,524

150,534

150,500

14,517

10,067

13,467

9,567

9,567

9,567

9,567

9,567

10,356

8,144

0

-

-

-

-

-

-

-

-

Line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,358

11,858

Notes payable to related party, including interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59,021

58,383

Total current liabilities

195,215

106,779

211,354

201,607

197,811

207,179

208,897

63,061

61,860

78,614

77,897

72,588

71,138

90,436

74,056

70,053

64,913

45,676

43,188

28,334

24,925

21,081

18,462

14,587

85,707

83,419

Operating lease liabilities

12,163

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent accrued litigation awards and settlements

125,000

125,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Uncertain income tax positions

3,861

3,767

5,999

8,901

8,765

5,692

8,172

8,188

7,950

7,933

7,608

7,380

7,390

8,544

7,831

3,736

3,736

3,778

-

-

-

-

-

-

-

-

Other noncurrent liabilities

85

81

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

336,324

235,627

217,353

210,508

206,576

212,871

217,069

71,249

69,810

86,547

85,505

79,968

78,528

98,980

81,887

73,789

68,649

49,454

43,188

28,334

24,925

21,081

18,462

14,587

85,707

83,419

Commitments and Contingencies (Note 8)

-

-

0

0

0

-

0

0

0

0

0

0

-

-

0

0

-

-

-

-

-

0

0

0

0

-

Stockholders' Deficit:
Preferred stock (par value $0.001 per share; 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

149

149

Common stock (par value $0.01 per share; 100,000,000 shares authorized; 74,513,286 and 74,381,303 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively)

745

744

743

742

738

736

731

727

721

719

718

716

715

719

720

718

713

707

348

345

7

332

5

5

0

-

Additional paid in capital

-

-

-

-

-

-

-

-

261,173

-

253,783

244,293

239,427

246,685

245,459

238,444

225,952

216,061

-

-

-

168,199

160,723

158,923

65,663

64,604

Additional paid in capital

295,634

292,508

289,534

286,556

282,048

278,356

273,909

267,968

-

256,529

-

-

-

-

-

-

-

-

205,061

193,123

178,705

-

-

-

-

-

Unrealized loss on available-for-sale securities, net of tax

-176

-269

-349

-438

-550

-438

-238

-251

-227

-302

-74

84

14

-152

33

-17

4

-24

-20

-5

-18

-

-

-

-

-

Notes receivable from stockholders

-

-

-

-

-

-

-

-

-

21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes receivable from stockholders

-

-

-

-

-

21

21

21

21

-

21

21

21

21

21

21

21

21

21

21

21

21

21

21

21

21

Accumulated deficit

-459,927

-336,083

-289,790

-262,223

-234,873

-212,424

-168,364

-2,044

6,140

12,664

16,316

13,391

7,364

5,074

-13,068

-37,699

-47,112

-51,056

-60,405

-71,910

-81,375

-89,033

-113,133

-124,720

-129,267

-129,410

Total stockholders' deficit

-163,724

-43,100

138

24,637

47,363

66,209

106,017

266,379

267,786

269,589

270,722

258,463

247,499

252,305

233,123

201,425

179,536

165,667

144,963

121,532

97,298

79,477

47,574

34,187

-63,476

-64,678

Total liabilities and stockholders' deficit

172,600

192,527

217,491

235,145

253,939

279,080

323,086

337,628

337,596

356,136

356,227

338,431

326,027

351,285

315,010

275,214

248,185

215,121

188,151

149,866

122,223

100,558

66,036

48,774

22,231

18,741